Anti-Diabetic API Supplier from India — WHO GMP Certified

Aarise Pharmaceuticals is a WHO GMP certified anti-diabetic API supplier based in Haridwar, India. We supply anti-diabetic active pharmaceutical ingredients used in the formulation of oral hypoglycaemic agents, insulin sensitisers, and DPP-4 inhibitors to formulation companies, generic drug manufacturers, and pharmaceutical importers across 18 countries. All APIs are available in USP, BP, and IP pharmacopeial grades with full regulatory documentation.

Molecules We Supply in This Category

Our anti-diabetic API range includes: Metformin HCl, Glimepiride, Sitagliptin, Glibenclamide, Voglibose — and additional molecules on request. Every batch is tested in our NABL-accredited QC laboratory for purity, impurity profile, residual solvents, and heavy metals.

Why Source Anti-Diabetic APIs from Aarise?

• WHO GMP Certified Facility — Haridwar manufacturing unit certified to WHO GMP standards
• NABL-Accredited QC Laboratory — all analytical testing done in-house; no outsourcing
• Full Regulatory Documentation — COA, MSDS, DMF, COPP, Certificate of Origin provided with every order
• Pharmacopeial Grade — USP / BP / IP grade APIs with 98–99%+ purity
• Global Export Experience — 18 countries, including regulated markets (USA, EU, Brazil)
• Fast Turnaround — 5–10 day standard lead time; sample available within 3–5 days

Export Markets

We actively export anti-diabetic APIs to buyers in Brazil (ANVISA), Colombia (INVIMA), Mexico (COFEPRIS), Germany and Netherlands (EMA), USA (FDA DMF), South Korea (MFDS), Argentina (ANMAT), Philippines, South Africa (SAHPRA), and across Southeast Asia and Africa.

Documentation Provided

• Batch-specific Certificate of Analysis (COA)
• MSDS / SDS in GHS format
• WHO GMP Certificate (current)
• Certificate of Pharmaceutical Product (COPP)
• Drug Master File (DMF) support for FDA, EMA, ANVISA, COFEPRIS, INVIMA, MFDS
• Certificate of Origin
• Stability data and shelf-life documentation

Request a Quote

To request pricing, samples, or regulatory documentation for anti-diabetic APIs, contact Aarise Pharmaceuticals at +91 9899783330 or fill in our inquiry form. We respond within 24 hours.

Frequently Asked Questions

What anti-diabetic APIs does Aarise supply?

Aarise Pharmaceuticals supplies Metformin HCl, Glimepiride, Sitagliptin, Glibenclamide, Voglibose and additional anti-diabetic molecules. Contact us for a full product list with CAS numbers, purity specifications, and pricing.

Is Aarise WHO GMP certified for anti-diabetic API supply?

Yes. Our Haridwar manufacturing facility is WHO GMP certified. We supply anti-diabetic APIs with full GMP documentation including COA, DMF support, and COPP for all major regulatory markets.

What is the minimum order quantity (MOQ) for anti-diabetic APIs?

MOQ starts from 100g for most APIs. We also offer sample quantities (10–50g) for formulation development and regulatory filing purposes.

Do you supply anti-diabetic APIs to regulated markets like USA, EU, and Brazil?

Yes. We export to 18 countries including FDA-regulated USA, EMA-regulated EU markets (Germany, Netherlands), and ANVISA-regulated Brazil. Full DMF and regulatory dossier support is available.

How quickly can Aarise deliver anti-diabetic API orders?

Standard lead time is 5–10 business days for stock molecules. Samples are dispatched within 3–5 business days. Rush orders can be accommodated on request.